Leukaemia treatment in heart scare2nd August 2006
A leukaemia treatment hailed as the next generation of cancer care, has been linked to heart failure.
About 2,500 people in Britain take Glivec, known generically as imatinib, which has transformed the treatment of chronic myeloid leukaemia (CML) since its launch in 2001.
Around nine out of 10 patients who take it are still alive after five years. Despite the research by American scientists claiming it can be dangerous to the heart in journal Nature Medicine, they advise patients continue treatment.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: Leukaemia treatment in heart scare
Author: Chris May
Article Id: 608
Date Added: 2nd Aug 2006